Keifei Retatrutifei 20mg x 3Vail

Retatrutide (also referred to as LY3437943) is an investigational 39-amino-acid triple receptor agonist engineered to simultaneously activate the GLP-1, GIP, and glucagon receptors. This multi-pathway mechanism distinguishes retatrutide from single- and dual-agonist incretin compounds currently available.
Receptor Targets:
GLP-1: Appetite regulation, gastric emptying modulation, insulinotropic effects
GIP: Insulin sensitivity enhancement, food reward signaling modulation
Glucagon: Energy expenditure, fat oxidation, hepatic lipid metabolism
Molecular Weight: Approximately 4,731 Da (as a 39-mer peptide)
Half-Life: Reported ~6 days (literature estimate)

Clinical Research Status
Retatrutide remains an investigational compound that has not received regulatory approval from the FDA, EMA, or any other national regulatory authority for human therapeutic use. All available evidence derives from controlled clinical trial settings.

Intended Use (Research Context Only)
This product is supplied strictly as a research-grade chemical reference material for:
In-vitro receptor binding and signaling studies
Analytical method development and validatio
Peptide characterization and stability testing
Laboratory-based metabolic pathway research

This product is NOT:
A therapeutic drug
A dietary supplement
A cosmetic agent
A food additive
For human or veterinary consumption

Storage and Handling
Pre-reconstitution storage2°C–8°C (refrigerated), protected from lightReconstitution solventBacteriostatic water or appropriate laboratory diluentPost-reconstitution stabilityShortened; follow standard peptide handling protocolsFreeze-thaw cyclesMinimize to preserve peptide integrity

Quality Documentation
Each Keifei Retatrutide 3-vial kit includes batch-specific documentation. Beast Muscle Egypt provides:
Certificate of Analysis (COA) indicating HPLC purity ≥99%
Mass spectrometry identity confirmation
Endotoxin testing data (where applicable
Laboratory researchers should independently verify all analytical data before experimental use.

Why Researchers Choose Beast Muscle Egypt
Authentic sourcing: Direct procurement from Keifei
Consistent inventory: Reliable stock for ongoing research protocols
Cold-chain shipping: Temperature-controlled logistics across Egypt
Documentation support: COAs available upon request
Local presence: Cairo-based operations with nationwide delivery

WARNING
This product is a research-grade chemical intended exclusively for laboratory and in-vitro research applications. It has not been evaluated or approved by the FDA, EMA, Egyptian Drug Authority (EDA), or any regulatory body for human or veterinary use.
Serious health risks have been documented with unapproved, non-pharmaceutical-grade retatrutide products obtained outside clinical trial settings, including:
Severe non-diabetic ketoacidosis requiring hospitalization
Pancreatitis, gallbladder disease, and severe gastrointestinal events
Hypersensitivity and anaphylactic reactions
Hypoglycemia risk, particularly when combined with other glucose-lowering agents

Note About BEAST MUSCLE

We always strive to update product images on our store according to the versions available to us. There may be some changes in manufacturing, packaging, components, or external appearance from the producing companies. Shipments may carry an alternative shape or a newer version than shown in our store, but this does not reduce the guarantee of quality and originality of the products. We recommend that you read the warnings and instructions for each product before use and do not rely solely on the information provided by BEAST MUSCLE.